Dantrolene inhibits Ca2+ leakage through RyR2 in CPVT or heart failure by allosterically increasing the binding affinity of CaM to RyR224,25. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.